Press Trust of India | Updated On: May 04, 2014 15:05 (IST)
').appendTo($('#gta_top')); $('').appendTo($('#gta_top')); },3000); /* s += ''; s += ''; */ } else if (google_ads.length > 1) { s += ''; } s += ' 
New Delhi:
Amid American firms' allegations of patent norm violations against Indian pharmaceutical companies, domestic drug maker Cipla has said that "essential" medicines should be made available to people at affordable rates and not be sold under "monopoly".
"As a scientist I believe that an inventor or innovator of a new drug should be suitably rewarded, no doubt about that. But then, if the drug is essential it should not be sold under monopoly," Cipla chairman Yusuf Hamied said.
The right to live should not be dependent on the ability to pay, said Mr Hamied, who was speaking here at the special screening of documentary 'Fire in the Blood'.
"It is important to ensure that essential life-saving and vital drugs are available at affordable prices not only in developing countries but worldwide," he added.
The documentary, which was screened by the Ministry of External Affairs, depicts mass devastation in Africa, Asia and other parts of the global South due to obstruction of low cost anti-retroviral drugs used for the treatment of HIV/AIDS.
"The right to live should not be dependent on the ability to pay, lives cannot be sacrificed at the altar of corporate profit and greed," Mr Hamied said.
The US pharma lobbies are pressuring their government to take action against India. They are alleging that Indian IPR laws discriminate against American companies. They have raised concerns regarding Swiss pharma major Novartis AG losing the legal battle for getting its blood cancer drug Glivec patented in India. They have also raised concerns over issuance of compulsory license by Indian government to a domestic firm.
Calling the pharmaceutical industry a 'healthcare custodian' of the world, Mr Hamied offered technology transfer to produce affordable drugs to the developing countries.
"I do believe that countries should take up this offer from India to provide technology to the developing world. The multinational companies are however are not interested in this type of transfer of technology to the developing world and therefore I strongly believe that countries should look at India to provide both technology and raw materials that go into the manufacturing of healthcare products," the Cipla chief said.
The campaign to fight HIV AIDS by the company way back in 2000 has helped to save over 10 million lives in Africa alone, he added.
"The AIDS initiative that Cipla pioneered has approximately saved almost 10 million lives in Africa alone. Today India produces 92 per cent of all the AIDS drugs formulations worldwide, selling them at a price of around $1 billion. The balance 8 per cent made by the MNCs is sold in the developed world for a price of over $16 billion," he said.
The overall success of an individual or a company or an industry can't be judged by its profitability or monetary gain, it is to be judged by its capacity and capability to contribute its moral and social obligations to society, he added.
RESULT
Mahatma Gandhi visited Cipla and inspired our founder to make essential and make them available and affordable for all drugs, thus making world
Cipla - Official Site
Cipla is a global pharmaceutical manufacturing company with a presence over 180 countries. Ensuring better health to all. Caring to excel. 40+ dosage forms 34
[e-drug] MSF/CIPLA ARV offer update - Essentialdrugs.org
however, need to register the CIPLA drugs for quality, increase access to essential medicines, More Affordable Anti-AIDS Drugs
Cipla chief calls for 'obligatory' drugs licenses ...
able to manufacture and market essential drugs to make them more as Cipla's managing and ensure access to affordable drugs."
Pharmaceutical Manufacturer - Cipla Medpro. We'll make it ...
We make quality medicines affordable. Read more >> For more information click here >> Cipla Medpro SA . Cipla Medpro is a leader in pharmaceutical manufacturing.
Cipla | Facebook
Cipla. 3,672 likes · 10 talking about multinational pharma companies and making some of the essential drugs more affordable to life-saving cancer drugs used
Cipla chief calls for 'obligatory' drugs licences ...
who stepped down as Cipla's managing and market drugs at an affordable to manufacture and market essential drugs to make them more
Cipla - Wikipedia, the free encyclopedia
Cipla makes drugs to treat cardiovascular disease, arthritis, diabetes, and therefore medicines should be made available at affordable prices.
Cipla chief calls for obligatory drugs licenses ...
For millions of people in the developing world, access to essential medicines is often a question of life and death. Most of them rely on the affordable
Cipla chief calls for obligatory drug licensing ...
chairman of Cipla, to manufacture and market drugs at an affordable be able to manufacture and market essential drugs to make them more
